EMEA-000236-PIP03-11

Key facts

Active substance
aflibercept
Therapeutic area
Ophthalmology
Decision number
P/186/2011
PIP number
EMEA-000236-PIP03-11
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of central retinal vein occlusion
Route(s) of administration
Intravitreal use
Contact for public enquiries
Bayer Schering Pharma AG
pediatrics.medical-affairs-europe@bayerhealthcare.com
Germany
Phone: +49 3046815333
Fax: +49 3046895333
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating